Envista Holdings Co. (NYSE:NVST) Given Consensus Rating of “Hold” by Analysts

Envista Holdings Co. (NYSE:NVST) has earned an average rating of “Hold” from the fourteen research firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $20.38.

A number of equities analysts have issued reports on NVST shares. Piper Sandler cut their price target on Envista from $18.00 to $17.00 and set a “neutral” rating for the company in a research note on Wednesday. Morgan Stanley set a $16.00 price objective on shares of Envista in a research report on Tuesday, April 15th. New Street Research set a $19.00 price target on Envista in a research report on Thursday, March 6th. Bank of America dropped their price target on shares of Envista from $26.00 to $23.00 and set a “buy” rating on the stock in a research note on Tuesday, April 29th. Finally, Jefferies Financial Group lifted their target price on Envista from $20.00 to $22.00 and gave the company a “hold” rating in a report on Thursday, January 23rd.

Envista Price Performance

Envista stock opened at $16.97 on Friday. The stock’s 50 day moving average price is $16.73 and its two-hundred day moving average price is $19.05. The stock has a market capitalization of $2.88 billion, a price-to-earnings ratio of -2.61, a PEG ratio of 1.27 and a beta of 1.12. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04. Envista has a 52-week low of $14.22 and a 52-week high of $23.00.

Envista (NYSE:NVST) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.04. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. The business had revenue of $616.90 million during the quarter, compared to analysts’ expectations of $608.17 million. During the same period last year, the company posted $0.26 earnings per share. The business’s quarterly revenue was down 1.1% on a year-over-year basis. On average, equities analysts predict that Envista will post 1 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of NVST. Ariel Investments LLC increased its position in shares of Envista by 6.2% in the fourth quarter. Ariel Investments LLC now owns 12,059,624 shares of the company’s stock valued at $232,630,000 after acquiring an additional 699,625 shares during the period. Franklin Resources Inc. grew its stake in shares of Envista by 72.6% in the fourth quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company’s stock worth $132,223,000 after purchasing an additional 2,882,844 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Envista by 19.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 6,762,091 shares of the company’s stock valued at $130,440,000 after purchasing an additional 1,089,923 shares during the period. Gates Capital Management Inc. raised its position in Envista by 15.1% during the 4th quarter. Gates Capital Management Inc. now owns 4,694,148 shares of the company’s stock valued at $90,550,000 after purchasing an additional 615,577 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its holdings in Envista by 9.5% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,271,175 shares of the company’s stock worth $63,101,000 after buying an additional 283,415 shares during the period.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.